Conquer liver disease with rapid, reliable imaging

In a single 15-minute noninvasive MRI procedure, LiverMultiScan provides three clinically significant metrics measuring fibro-inflammation by iron-corrected T1 (cT1), liver fat, measured by proton density fat fraction (PDFF), and correlates of liver iron levels (T2*) to help assess the extent of liver disease.

LiverMultiScan is the only technology measuring cT1, a proprietary biomarker that measures the level of fibro-inflammation, offering the potential for earlier diagnosis even at the stage when disease progression can still be stopped and reversed, as well as monitoring of disease progression or regression.

Providers

Patients

Play

1-in-3 Americans are afflicted by liver disease, so there’s no time to wait.

LiverMultiScan can help identify patients with liver disease, where other tools cannot, helping clinicians determine treatment pathways and, because it is repeatable, monitor progress to help reduce the risk of progression and serious complications.

Learn More

Diagnose Early

Learn More

Predict Prognosis

Learn More

Monitor Progress

Learn More
Play

1-in-3 Americans are afflicted by liver disease, so there’s no time to wait.

Chronic liver disease is often a silent condition and can cause serious complications. Early detection is key to reversing the disease before it’s too late. LiverMultiScan allows your doctor to create a treatment plan aimed at potentially reversing liver disease.

Learn More

Open

Close

Contact Form

Stay up to date on the latest news and clinical research on LiverMultiScan